Cargando…
Community Pharmacy Engagement in Diabetes Prevention: Key Informant Interviews with Pharmacy Executives
INTRODUCTION: Even though evidence-based diabetes prevention interventions exist, more than 1 in 3 Americans have prediabetes; the use of pharmacies has been explored as a way to reach and care for this population. The objective of this study was to analyze factors that influence adoption of type 2...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458117/ https://www.ncbi.nlm.nih.gov/pubmed/32816661 http://dx.doi.org/10.5888/pcd17.200050 |
_version_ | 1783576130748416000 |
---|---|
author | Roszak, Sara E. Ferreri, Stefanie P. |
author_facet | Roszak, Sara E. Ferreri, Stefanie P. |
author_sort | Roszak, Sara E. |
collection | PubMed |
description | INTRODUCTION: Even though evidence-based diabetes prevention interventions exist, more than 1 in 3 Americans have prediabetes; the use of pharmacies has been explored as a way to reach and care for this population. The objective of this study was to analyze factors that influence adoption of type 2 diabetes prevention programs by community pharmacies. METHODS: We conducted 21 semistructured interviews in 2018 with decision makers from 11 independent pharmacies in 6 US states and the District of Columbia and from 10 chain pharmacies operating in 1 state, multiple states, and nationwide. We identified participants by using purposive sampling. We used qualitative methods to analyze data and conducted interviews until we reached saturation. RESULTS: Multiple themes emerged: 1) initiation of services is more likely if initial financial support is received; 2) patient demand for services, actual or perceived, is paramount; 3) diabetes prevention services often fit within the existing operations of a pharmacy and allow maximum use of resources; 4) customer loyalty is a clearly articulated advantage against competition; and 5) engagement in diabetes prevention affirms an expanded role and the value of pharmacies to serve communities. CONCLUSION: Pharmacies are well situated to deliver diabetes prevention programs to communities. Although considerable opportunity exists for pharmacies to address diabetes prevention, more could be done to reduce barriers to their use. |
format | Online Article Text |
id | pubmed-7458117 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-74581172020-09-04 Community Pharmacy Engagement in Diabetes Prevention: Key Informant Interviews with Pharmacy Executives Roszak, Sara E. Ferreri, Stefanie P. Prev Chronic Dis Original Research INTRODUCTION: Even though evidence-based diabetes prevention interventions exist, more than 1 in 3 Americans have prediabetes; the use of pharmacies has been explored as a way to reach and care for this population. The objective of this study was to analyze factors that influence adoption of type 2 diabetes prevention programs by community pharmacies. METHODS: We conducted 21 semistructured interviews in 2018 with decision makers from 11 independent pharmacies in 6 US states and the District of Columbia and from 10 chain pharmacies operating in 1 state, multiple states, and nationwide. We identified participants by using purposive sampling. We used qualitative methods to analyze data and conducted interviews until we reached saturation. RESULTS: Multiple themes emerged: 1) initiation of services is more likely if initial financial support is received; 2) patient demand for services, actual or perceived, is paramount; 3) diabetes prevention services often fit within the existing operations of a pharmacy and allow maximum use of resources; 4) customer loyalty is a clearly articulated advantage against competition; and 5) engagement in diabetes prevention affirms an expanded role and the value of pharmacies to serve communities. CONCLUSION: Pharmacies are well situated to deliver diabetes prevention programs to communities. Although considerable opportunity exists for pharmacies to address diabetes prevention, more could be done to reduce barriers to their use. Centers for Disease Control and Prevention 2020-08-20 /pmc/articles/PMC7458117/ /pubmed/32816661 http://dx.doi.org/10.5888/pcd17.200050 Text en https://creativecommons.org/licenses/by/4.0/Preventing Chronic Disease is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Original Research Roszak, Sara E. Ferreri, Stefanie P. Community Pharmacy Engagement in Diabetes Prevention: Key Informant Interviews with Pharmacy Executives |
title | Community Pharmacy Engagement in Diabetes Prevention: Key Informant Interviews with Pharmacy Executives |
title_full | Community Pharmacy Engagement in Diabetes Prevention: Key Informant Interviews with Pharmacy Executives |
title_fullStr | Community Pharmacy Engagement in Diabetes Prevention: Key Informant Interviews with Pharmacy Executives |
title_full_unstemmed | Community Pharmacy Engagement in Diabetes Prevention: Key Informant Interviews with Pharmacy Executives |
title_short | Community Pharmacy Engagement in Diabetes Prevention: Key Informant Interviews with Pharmacy Executives |
title_sort | community pharmacy engagement in diabetes prevention: key informant interviews with pharmacy executives |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458117/ https://www.ncbi.nlm.nih.gov/pubmed/32816661 http://dx.doi.org/10.5888/pcd17.200050 |
work_keys_str_mv | AT roszaksarae communitypharmacyengagementindiabetespreventionkeyinformantinterviewswithpharmacyexecutives AT ferreristefaniep communitypharmacyengagementindiabetespreventionkeyinformantinterviewswithpharmacyexecutives |